Page last updated: 2024-09-03

2-(2,3-dicarboxycyclopropyl)glycine and phencyclidine

2-(2,3-dicarboxycyclopropyl)glycine has been researched along with phencyclidine in 3 studies

Compound Research Comparison

Studies
(2-(2,3-dicarboxycyclopropyl)glycine)
Trials
(2-(2,3-dicarboxycyclopropyl)glycine)
Recent Studies (post-2010)
(2-(2,3-dicarboxycyclopropyl)glycine)
Studies
(phencyclidine)
Trials
(phencyclidine)
Recent Studies (post-2010) (phencyclidine)
16602728,2943877,796

Protein Interaction Comparison

ProteinTaxonomy2-(2,3-dicarboxycyclopropyl)glycine (IC50)phencyclidine (IC50)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)0.1299
Lysosomal Pro-X carboxypeptidaseHomo sapiens (human)0.091
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)0.1299
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.1299
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)0.1299
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)0.5563
Glutamate receptor ionotropic, NMDA 2AHomo sapiens (human)0.205
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)1.2589
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)0.1299
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)0.1299
Sigma non-opioid intracellular receptor 1Rattus norvegicus (Norway rat)0.53
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)0.1299

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maeda, J; Okauchi, T; Semba, J; Suhara, T1
Barda, D; Britton, TC; Emkey, R; Hornback, WJ; Jagdmann, GE; Johnson, MP; McKinzie, DL; Nisenbaum, ES; Schoepp, DD; Tizzano, JP1
Bortolotto, Z; Ceolin, L; Collingridge, G; Hanna, L; Johnson, B; Lodge, D; Lucas, S; Monn, J1

Other Studies

3 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and phencyclidine

ArticleYear
Different roles of group I and group II metabotropic glutamate receptors on phencyclidine-induced dopamine release in the rat prefrontal cortex.
    Neuroscience letters, 2003, Jan-23, Volume: 336, Issue:3

    Topics: Animals; Anticonvulsants; Cycloleucine; Cyclopropanes; Dopamine; Dopamine Agents; Excitatory Amino Acid Antagonists; Extracellular Space; Glycine; Hallucinogens; Male; Microdialysis; Neuroprotective Agents; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Time Factors

2003
Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s).
    Psychopharmacology, 2005, Volume: 179, Issue:1

    Topics: Animals; Anxiety; Cyclopropanes; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Glycine; Humans; Male; Mice; Mice, Inbred DBA; Mice, Inbred ICR; Motor Activity; Phencyclidine; Psychotic Disorders; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Synaptic Transmission

2005
Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist.
    Neuropharmacology, 2013, Volume: 66

    Topics: Amino Acids, Dicarboxylic; Amphetamine; Animals; Bridged Bicyclo Compounds; Cyclopropanes; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glycine; Hippocampus; Mice; Mice, Inbred ICR; Mice, Knockout; Motor Activity; Phencyclidine; Receptors, Metabotropic Glutamate; Synaptic Transmission

2013